296 related articles for article (PubMed ID: 30694842)
1. New perspectives in Merkel cell carcinoma.
Del Marmol V; Lebbé C
Curr Opin Oncol; 2019 Mar; 31(2):72-83. PubMed ID: 30694842
[TBL] [Abstract][Full Text] [Related]
2. Immune Checkpoint Inhibitors and Beyond: An Overview of Immune-Based Therapies in Merkel Cell Carcinoma.
Samimi M
Am J Clin Dermatol; 2019 Jun; 20(3):391-407. PubMed ID: 30784027
[TBL] [Abstract][Full Text] [Related]
3. Recent Therapeutic Advances and Change in Treatment Paradigm of Patients with Merkel Cell Carcinoma.
Garcia-Carbonero R; Marquez-Rodas I; de la Cruz-Merino L; Martinez-Trufero J; Cabrera MA; Piulats JM; Capdevila J; Grande E; Martin-Algarra S; Berrocal A
Oncologist; 2019 Oct; 24(10):1375-1383. PubMed ID: 30962295
[TBL] [Abstract][Full Text] [Related]
4. Updates on Merkel Cell Carcinoma.
Emge DA; Cardones AR
Dermatol Clin; 2019 Oct; 37(4):489-503. PubMed ID: 31466589
[TBL] [Abstract][Full Text] [Related]
5. Current concepts and approaches to merkel cell carcinoma.
Babadzhanov M; Doudican N; Wilken R; Stevenson M; Pavlick A; Carucci J
Arch Dermatol Res; 2021 Apr; 313(3):129-138. PubMed ID: 32666149
[TBL] [Abstract][Full Text] [Related]
6. Immunotherapy for Merkel Cell Carcinoma.
Nagase K; Narisawa Y
Curr Treat Options Oncol; 2018 Sep; 19(11):57. PubMed ID: 30238195
[TBL] [Abstract][Full Text] [Related]
7. [Immune checkpoint inhibition in Merkel cell carcinoma].
Terheyden P; Mohr A; Langan EA
Hautarzt; 2019 Sep; 70(9):684-690. PubMed ID: 31468071
[TBL] [Abstract][Full Text] [Related]
8. Advances in Immunotherapy for Metastatic Merkel Cell Carcinoma: A Clinician's Guide.
Paulson KG; Bhatia S
J Natl Compr Canc Netw; 2018 Jun; 16(6):782-790. PubMed ID: 29891528
[TBL] [Abstract][Full Text] [Related]
9. Real-world clinical outcomes with first-line avelumab in locally advanced/metastatic Merkel cell carcinoma in the USA: SPEAR-Merkel.
Cowey CL; Liu FX; Kim R; Boyd M; Fulcher N; Krulewicz S; Kasturi V; Bhanegaonkar A
Future Oncol; 2021 Jun; 17(18):2339-2350. PubMed ID: 33709776
[TBL] [Abstract][Full Text] [Related]
10. Merkel cell carcinoma: Epidemiology, pathogenesis, diagnosis and therapy.
Amaral T; Leiter U; Garbe C
Rev Endocr Metab Disord; 2017 Dec; 18(4):517-532. PubMed ID: 28916903
[TBL] [Abstract][Full Text] [Related]
11. Scientific and clinical developments in Merkel cell carcinoma: A polyomavirus-driven, often-lethal skin cancer.
Akaike T; Nghiem P
J Dermatol Sci; 2022 Jan; 105(1):2-10. PubMed ID: 34836718
[TBL] [Abstract][Full Text] [Related]
12. Metastatic Merkel-cell carcinoma: the dawn of a new era.
O'Brien T; Power DG
BMJ Case Rep; 2018 Jul; 2018():. PubMed ID: 30002209
[TBL] [Abstract][Full Text] [Related]
13. Merkel Cell Carcinoma in the Age of Immunotherapy: Facts and Hopes.
Colunga A; Pulliam T; Nghiem P
Clin Cancer Res; 2018 May; 24(9):2035-2043. PubMed ID: 29217527
[TBL] [Abstract][Full Text] [Related]
14. Merkel Cell Carcinoma: Integrating Epidemiology, Immunology, and Therapeutic Updates.
Becker JC; Stang A; Schrama D; Ugurel S
Am J Clin Dermatol; 2024 Jul; 25(4):541-557. PubMed ID: 38649621
[TBL] [Abstract][Full Text] [Related]
15. Recent Insights and Advances in the Management of Merkel Cell Carcinoma.
Banks PD; Sandhu S; Gyorki DE; Johnston ML; Rischin D
J Oncol Pract; 2016 Jul; 12(7):637-46. PubMed ID: 27407160
[TBL] [Abstract][Full Text] [Related]
16. Avelumab and other recent advances in Merkel cell carcinoma.
Bommareddy PK; Kaufman HL
Future Oncol; 2017 Dec; 13(30):2771-2783. PubMed ID: 28976209
[TBL] [Abstract][Full Text] [Related]
17. Merkel Cell Carcinoma Therapeutic Update.
Cassler NM; Merrill D; Bichakjian CK; Brownell I
Curr Treat Options Oncol; 2016 Jul; 17(7):36. PubMed ID: 27262710
[TBL] [Abstract][Full Text] [Related]
18. PD-L1 inhibition with avelumab for metastatic Merkel cell carcinoma.
Gaiser MR; Bongiorno M; Brownell I
Expert Rev Clin Pharmacol; 2018 Apr; 11(4):345-359. PubMed ID: 29478343
[TBL] [Abstract][Full Text] [Related]
19. Avelumab expanded access program in metastatic Merkel cell carcinoma: Efficacy and safety findings from patients in Europe and the Middle East.
Ascierto PA; Orlova K; Grignani G; Dudzisz-Śledź M; Fenig E; Chiarion Sileni V; Fazio N; Samimi M; Mortier L; Gebhardt C; Kramkimel N; Steven N; Bechter O; Arance A; Benincasa E; Kostkova L; Costa N; Lorigan P
Int J Cancer; 2021 Dec; 149(11):1926-1934. PubMed ID: 34310716
[TBL] [Abstract][Full Text] [Related]
20. Caring for Patients Treated With Checkpoint Inhibitors for the Treatment of Metastatic Merkel Cell Carcinoma.
Rubin KM; Hoffner B; Bullock AC
Semin Oncol Nurs; 2019 Oct; 35(5):150924. PubMed ID: 31514991
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]